0

506373

CITURGIA

img img img img
No Data Available

CITURGIA BIOCHEMICALS LTD. Share Price Update

As of the latest trading session, CITURGIA BIOCHEMICALS LTD. share price is currently at ₹54.86, which is up by ₹2.61 from its previous closing. Today, the stock has fluctuated between ₹54.86 and ₹54.86. Over the past year, CITURGIA BIOCHEMICALS LTD. has achieved a return of [-]%. In the last month alone, the return has been [-]%.

CITURGIA BIOCHEMICALS LTD. fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    724.70

  • P/E Ratio (TTM)

    -1,828.67

  • Beta

    3.77

  • Book Value / share

    -0.74

  • Return on equity

    0.00%

  • EPS (TTM)

    0.00

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    -0.11

info icon alternate text

CITURGIA BIOCHEMICALS LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.29
Net Profit -0.29
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.00
EBITDA -0.22
Effective Tax Rate (%) 0.00
Particulars SEP 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.11
Net Profit -0.11
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.00
EBITDA -0.05
Effective Tax Rate (%) 0.00
Particulars JUN 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.08
Net Profit -0.08
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.01
EBITDA -0.03
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.12
Net Profit -0.12
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.01
EBITDA -0.06
Effective Tax Rate (%) 0.00
Particulars DEC 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.10
Net Profit -0.10
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.01
EBITDA -0.04
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.42
Net Profit -0.42
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.02
EBITDA -0.18
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.48
Net Profit -0.48
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.03
EBITDA -0.24
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 0.00
Operating Expense 0.44
Net Profit -0.44
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.03
EBITDA -0.21
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 0.00
Operating Expense 0.40
Net Profit -0.40
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.03
EBITDA -0.17
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 0.00
Operating Expense 0.61
Net Profit -0.61
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.05
EBITDA -0.37
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share -3.59
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share -3.43
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share -3.25
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share -3.09
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2021 (Values in Cr)
Book Value / Share -2.93
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.11
Total Assets 10.76
Total Liabilities 10.76
Total Equity -6.99
Share Outstanding 2
Price to Book Ratio 0.00
Return on Assets (%) -3.93
Return on Capital (%) 267.75
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.10
Total Assets 11.04
Total Liabilities 11.04
Total Equity -6.56
Share Outstanding 2
Price to Book Ratio 0.00
Return on Assets (%) -4.30
Return on Capital (%) -236.53
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.07
Total Assets 11.19
Total Liabilities 11.19
Total Equity -6.09
Share Outstanding 2
Price to Book Ratio 0.00
Return on Assets (%) -3.89
Return on Capital (%) -95.11
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.05
Total Assets 11.42
Total Liabilities 11.42
Total Equity -5.65
Share Outstanding 2
Price to Book Ratio 0.00
Return on Assets (%) -3.53
Return on Capital (%) -48.18
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.06
Total Assets 11.59
Total Liabilities 11.59
Total Equity -5.25
Share Outstanding 2
Price to Book Ratio 0.00
Return on Assets (%) -5.27
Return on Capital (%) -49.23
Particulars MAR 2025 (Values in Cr)
Net Income -0.42
Cash from Operations -0.11
Cash from Investing 0.06
Cash from Financing 0.06
Net change in Cash 0.01
Free Cash Flow -0.11
Particulars MAR 2024 (Values in Cr)
Net Income -0.47
Cash from Operations -0.14
Cash from Investing -0.05
Cash from Financing 0.21
Net change in Cash 0.02
Free Cash Flow -0.14
Particulars MAR 2023 (Values in Cr)
Net Income -0.43
Cash from Operations -0.06
Cash from Investing 0.03
Cash from Financing 0.05
Net change in Cash 0.02
Free Cash Flow -0.06
Particulars MAR 2022 (Values in Cr)
Net Income -0.40
Cash from Operations -0.02
Cash from Investing 0.01
Cash from Financing 0.00
Net change in Cash -0.01
Free Cash Flow -0.02
Particulars MAR 2021 (Values in Cr)
Net Income -0.61
Cash from Operations -0.14
Cash from Investing 0.14
Cash from Financing 0.01
Net change in Cash 0.00
Free Cash Flow -0.14
Company Name Price P/E P/B Market Cap 52 Week Low/High
ATUL LTD 6617.30 32.78 3.29 19482.49 4882.00 / 7793.00
BASF INDIA LTD 3659.85 42.95 4.18 15841.89 3522.85 / 5418.20
ORIENTAL AROMATICS LIMITED 298.80 0.00 1.51 1005.57 250.35 / 430.00
DEEPAK FERTILISERS & PETROCHEM 1030.85 14.87 1.99 13013.23 888.25 / 1776.95
DEEPAK NITRITE LTD 1648.10 41.47 4.07 22478.94 1512.80 / 2255.05
Company Name Price P/E P/B Market Cap 52 Week Low/High
ADVANCE PETROCHEMICALS LTD. 143.70 261.27 3.47 12.93 130.20 / 242.00
ATUL LTD 6617.30 37.69 3.35 19482.49 4882.00 / 7793.00
BASF INDIA LTD 3659.85 41.18 4.15 15841.89 3522.85 / 5418.20
ORIENTAL AROMATICS LIMITED 298.80 32.06 1.45 1005.57 250.35 / 430.00

CITURGIA BIOCHEMICALS LTD. shareholding pattern

Holding

0.63%
99.36%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

CITURGIA BIOCHEMICALS LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
54.86 4.99 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 46.30
  • 26 Days 35.00
  • 10 Days 40.40
  • 50 Days 33.70
  • 12 Days 39.00
  • 100 Days 33.50
  • 20 Days 36.00
  • 200 Days 33.90
52.25 PIVOT

First Support

52.25

First Resistance

52.25

Second Support

52.25

Second Resistance

52.25

Third Support

52.25

Third Resistance

52.25

RSI

0.00

ADX

21.99

MACD

4.04

Williams % R

0.00

Commodity Channel Index (CCI)

255.06

Date

2026-02-13

Week

578.00

Same Day

85.00

Month

578.00

1 Year

3.77

3 Year

3.36

Over 1 Month

0.00%

down

Over 1 Year

0.00%

down

Over 3 Months

0.00%

down

Over 3 Years

0.00%

down

Over 6 Months

0.00%

down

Over 5 Years

0.00%

down

CITURGIA BIOCHEMICALS LTD. Corporate Actions

Ex-Date Old FV NEW FV Record Date
26 Apr 2018 10.0 2.0 30 Apr 2018

Top Gainers

CITURGIA BIOCHEMICALS LTD. Share Price

Engaged in the manufacture of citric acid, calcium carbonate and plasticisers, Citurgia Biochemicals Limited was promoted by John E Sturge, UK; Bombay Dyeing and Manufacturing Company; and Sturdia Chemicals. The Promoter, John E Sturge was repayed its entire equity holding in 1987-88, which reduced the equity capital. In 1987-88, it acquired two subsidiaries, Sodality Trading & Agencies and Himgiri Trading & Agencies.

Citric acid is traditionally used in foods, soft drinks, confectionery and drugs. It is also used in textile printing and dyeing, where it provides stable pH conditions for polyester and nylon, acrylic print-curing and cotton-resist printing. The company exports citric acid to the US, Japan, Germany, Australia, Iran, Malaysia, Sri Lanka, etc.

In 1988, the company successfully commissioned an anaerobic effluent- treatment plant to treat the effluents discharged during the manufacture of citric acid. It also increased production capacities by implementing expansion and modernisation schemes.

The modernization of coal fired boiler into a Fluidized Bed Combustion(FBC) coal fired boiler was completed.

The wholly owned subsidiary, Jasper Investments Limited was merged with the Company through the Scheme of Amalgamation, making it effective from October 1, 2002. The lock out was declared at Rishikesh factory, with effect from 29th September, 2003.

After registration of the Company's reference by the Hon'ble Board for Industrial & Financial Reconstruction (BIFR) in May, 2003, the first hearing of BIFR took place on July 19, 2005. In the said hearing, BIFR passed an Order declaring the Company as sick industrial company and also appointed the Union Bank of India as Operating Agency to examine the viability of the Company and formulate a rehabilitation scheme based on the Company's proposal for its revival.

The renovation at the Rishikesh plant started during the year 2007. The Rishikesh Plant for manufacturing of the calcium carbonate which was lying closed for last more than four years was renovated completely was put to production during 2008. The building construction work of residential complex at Rishikesh site was started in the Real Estate Division of the Company in 2010.

The Company's operations at calcium carbonate division remained suspended throughout the year for the want of working capital and clearance from the Uttarakhand Environment Protection and Pollution Control Board. The appeal filed by the Company before Hon'ble Supreme Court against the order of Hon'ble High Court of Uttarakhand granting stay the Rehabilitation Scheme passed by Hon'ble BIFR is still pending.

Parent organization MNC Associate
NSE symbol CITURGIBIO
Founded 1974
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Citurgia Biochemicals Ltd?

Answer Field

Citurgia Biochemicals Ltd share price is for NSE ₹ 18.00 & for BSE ₹ 54.86 as on Feb 13 2026 03:12 PM.

What is the Market Cap of Citurgia Biochemicals Ltd Share?

Answer Field

The market cap of Citurgia Biochemicals Ltd for NSE ₹ 0.00 & for BSE ₹ 724.70 as on Feb 13 2026 03:12 PM.

What is the 52 Week High and Low of Citurgia Biochemicals Ltd?

Answer Field

The 52 Week High and Low of Citurgia Biochemicals Ltd for NSE is ₹ 18.75 and ₹ 0.00 and for BSE is ₹ 54.86 and ₹ 47.40.

What is 1 year return for Citurgia Biochemicals Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the P/E Ratio of Citurgia Biochemicals Ltd Share?

Answer Field

As on Feb 13 2026 03:12 PM the price-to-earnings (PE) ratio for Citurgia Biochemicals Ltd share is -1828.67.

What is the PB ratio of Citurgia Biochemicals Ltd Share?

Answer Field

As on Feb 13 2026 03:12 PM, the price-to-book (PB) ratio for Citurgia Biochemicals Ltd share is -0.74.

How to Buy Citurgia Biochemicals Ltd Share?

Answer Field

You can trade in Citurgia Biochemicals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Citurgia Biochemicals Ltd Share on Bajaj Broking App?

Answer Field

To buy Citurgia Biochemicals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Citurgia Biochemicals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59